Logo

Genedata, Novartis Expand Lead Discovery Collaboration

May 16, 2006

NEW YORK, May 16 (GenomeWeb News) - Genedata said today that it has expanded a collaboration with the Novartis Institutes for Biomedical Research in the area of high-throughput screening analysis.

 

Under the terms of the expanded collaboration, Novartis will use the Genedata Screener software platform at its sites in Cambridge, Mass., and Basel, Switzerland.

 

The companies began the software collaboration in 2003.

 

Additional terms were not disclosed.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.